Troutman Pepper advised HMP Global, a leading omnichannel health care education, events, and market insights company, in its acquisition of Drug Channels Institute (DCI), a well-known and trusted source of market intelligence and analysis covering the $1.5 trillion pharmaceutical landscape. Read a company announcement about the deal here.
Founded in 2012, DCI helps its customers make sense of pharmaceutical economics and the increasingly complex pharmacy distribution and reimbursement system through data-driven insights, research, timely analysis, and highly regarded perspectives. The DCI acquisition aligns seamlessly with HMP Global’s strategic vision to further diversify its portfolio and accelerate its position in healthcare market analysis and intelligence.
The Troutman Pepper team advising HMP Global in the transaction was led by Partners Brandon Raphael and Matt Greenberg and included Raffaele Cicala, Matthew Ramsey, Monica Vu, and Laura Kleinberg. HMP Global is a portfolio company of firm client Susquehanna Growth Equity, a middle market private equity firm.